[1]
Anwar, S.R.M., Hidayati, P.H. and Hamzah, P.N. 2026. The Role of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Cardiovascular Complications in Type 2 Diabetes Mellitus . Journal of Asian-african Focus in Health. 4, 3 (Sep. 2026), 15–26. DOI:https://doi.org/10.71435/741778.